WallStreetZenWallStreetZen
Analyst Ranking
Top 22%
#1010 out of 4544 analysts
Average Return
+8.65%
Win Rate
43%16 out of 37
Risk vs Reward
Poor
Good

Akash Tewari's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Apogee Therapeutics IncAPGE
+156.52%$21.46$55.05
2023-08-07 -
2024-04-12
Strong Buy
Apogee Therapeutics IncAPGE
+156.52%$21.46$55.05
2023-08-07 -
2024-04-12
Strong Buy
Global Blood Therapeutics IncGBT
+139.48%$27.81$66.60
2021-10-06 -
2022-08-08
Strong Buy
Spyre Therapeutics IncSYRE
+107.70%$18.05$37.49
2023-12-10 -
2024-04-12
Strong Buy
Cytokinetics IncCYTK
+64.33%$22.82$37.50
2021-03-11 -
2022-03-11
Buy

Akash Tewari's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Alkermes PLCALKS
2Strong Buy$50.00+104.75%Maintains
5 days ago
Apogee Therapeutics IncAPGE
4Strong Buy$75.00+36.24%Maintains
a month ago
Apellis Pharmaceuticals IncAPLS
1Strong Buy$80.00+54.47%Upgrades
2 months ago
Spyre Therapeutics IncSYRE
1Strong Buy$31.00-17.31%Initiates Coverage On
4 months ago
Arvinas IncARVN
2Strong Buy$40.00+10.22%Upgrades
4 months ago
Regeneron Pharmaceuticals IncREGN
4Strong Buy$937.00+3.57%Maintains
5 months ago
Acelyrin IncSLRN
2Strong Buy$12.00+123.46%Maintains
5 months ago
Pfizer IncPFE
2Strong Buy$39.00+50.81%Upgrades
6 months ago
Eli Lilly & CoLLY
4Strong Buy$615.00-18.18%Upgrades
8 months ago
Enanta Pharmaceuticals IncENTA
2Hold$18.00+9.42%Downgrades
8 months ago
Argenx SeARGX
2Strong Buy$513.00+35.71%Maintains
9 months ago
Terns Pharmaceuticals IncTERN
1Strong Buy$18.00+250.19%Initiates Coverage On
10 months ago
Relay Therapeutics IncRLAY
2Hold$12.50+77.81%Upgrades
a year ago
Merck & Co IncMRK
1Strong Buy$125.00N/AInitiates Coverage On
a year ago
Bristol Myers Squibb CoBMY
1Hold$62.00N/AInitiates Coverage On
a year ago
Zymeworks IncZYME
1Strong Buy$11.00N/AUpgrades
a year ago
Third Harmonic Bio IncTHRD
2Hold$3.60N/ADowngrades
a year ago
Acrivon Therapeutics IncACRV
1Strong Buy$17.00N/AInitiates Coverage On
a year ago
Biomarin Pharmaceutical IncBMRN
1Strong Buy$120.00N/AMaintains
a year ago
Eqrx IncEQRX
2Hold$3.20N/ADowngrades
a year ago
Global Blood Therapeutics IncGBT
3Hold$68.50N/ADowngrades
2 years ago
Neurocrine Biosciences IncNBIX
1Strong Buy$112.00N/AAssumes
2 years ago
Cytokinetics IncCYTK
2Strong Buy$75.00N/AInitiates Coverage On
3 years ago
Madrigal Pharmaceuticals IncMDGL
1Strong Buy$151.00N/AInitiates Coverage On
3 years ago
Exelixis IncEXEL
2Strong Buy$28.00N/AInitiates Coverage On
3 years ago
Acceleron Pharma IncXLRN
2Hold$180.00N/AInitiates Coverage On
3 years ago
Biontech SeBNTX
1Hold$230.00N/AInitiates Coverage On
3 years ago
Horizon Therapeutics Public Ltd CoHZNP
1Buy$107.00N/AInitiates Coverage On
3 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.